Retour
Fourchette du Jour
17,86 €
19,77 €
Fourchette 52 Semaines
13,25 €
30,00 €
Volume
474 906
Moyenne 50J / 200J
23,97 €
/
22,08 €
Clôture Précédente
19,10 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -10,1 | 0,4 |
| P/B | 5,6 | 2,9 |
| ROE % | — | 3,8 |
| Net Margin % | -190,3 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,2 | 0,2 |
Points Clés
Debt/Equity of 0,22 — conservative balance sheet
Negative free cash flow of -101,20M
Capital intensive — 39,44% of revenue goes to capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)115,05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC-31,95%
Net Margin-190,28%
Op. Margin-177,85%
Sécurité
Debt / Equity
0,22
Current Ratio6,72
Interest Coverage-13,75
Valorisation
P/E Ratio
-10,05
P/B Ratio5,57
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 115,05% | Revenue Growth (3Y) | 179,99% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 59,82M | Net Income (TTM) | -113,81M |
| ROE | N/A | ROA | -38,48% |
| Gross Margin | 40,47% | Operating Margin | -177,85% |
| Net Margin | -190,28% | Free Cash Flow (TTM) | -101,20M |
| ROIC | -31,95% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,22 | Current Ratio | 6,72 |
| Interest Coverage | -13,75 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -10,05 | P/B Ratio | 5,57 |
| P/S Ratio | 19,12 | PEG Ratio | -0,07 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,14B | Enterprise Value | 950,25M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 59,82M | 27,81M | 7,63M | 0,0 | 0,0 |
| Net Income | -113,81M | -94,12M | -84,24M | -34,10M | -29,47M |
| EPS (Diluted) | -5,13 | -2,04 | -1,75 | -0,69 | -0,59 |
| Gross Profit | 24,21M | 362 000,0 | -10,65M | 0,0 | 0,0 |
| Operating Income | -106,38M | -85,06M | -80,42M | -32,71M | -29,32M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 295,74M | 45,95M | 38,66M | 30,52M | 7,87M |
| Total Liabilities | 90,34M | 255,33M | 156,23M | 28,76M | 4,02M |
| Shareholders' Equity | 205,41M | -209,38M | -117,58M | 1,77M | 3,86M |
| Total Debt | 44,31M | 45,17M | 39,13M | 22,85M | 452 000,0 |
| Cash & Equivalents | 237,60M | 8,25M | 14,81M | 24,34M | 5,76M |
| Current Assets | 255,33M | 14,91M | 18,42M | 26,20M | 6,17M |
| Current Liabilities | 37,98M | 32,97M | 36,74M | 6,61M | 4,02M |